- Investing Ideas
- /
- French Pharmaceuticals & Biotech Financially Fit Penny Stocks
French Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
6
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
6 companies
Aelis Farma
Market Cap: €16.8m
A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.
AELIS
€1.23
7D
8.8%
1Y
-90.5%
Valbiotis
Market Cap: €15.8m
Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.
ALVAL
€1.00
7D
-6.5%
1Y
-74.7%
Innate Pharma
Market Cap: €142.8m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.70
7D
-1.2%
1Y
-27.0%
Cellectis
Market Cap: €93.9m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.
ALCLS
€1.30
7D
18.4%
1Y
-48.3%
genOway Société anonyme
Market Cap: €27.3m
A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.
ALGEN
€2.96
7D
11.3%
1Y
-27.3%
ABIONYX Pharma
Market Cap: €40.2m
A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
ABNX
€1.16
7D
-4.1%
1Y
3.6%